+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review

  • ID: 4278827
  • SWOT Analysis
  • May 2020
  • 46 pages
  • GlobalData
  • Nevro Corp
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • NeuSpera Medical Inc
  • Saluda Medical Pty Ltd
  • Stimwave Technologies Inc
  • MORE
Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II and the Nevro logo brands. Nevro is developing HF10 therapy for treating painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp Key Recent Developments

May 05, 2020: Nevro reports first quarter 2020 financial results
Apr 01, 2020: Nevro provides first quarter and FY2020 update
Jan 20, 2020: Nevro names Donald A. Middlebrook to lead clinical, regulatory and quality
Jan 14, 2020: Nevro announces preliminary unaudited fourth quarter and full year 2019 revenue
Dec 18, 2019: ­Nevro appoints Karen N. Prange to the company's board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • NeuSpera Medical Inc
  • Saluda Medical Pty Ltd
  • Stimwave Technologies Inc
  • MORE
List of Tables

List of Figures

Section 1 - About the Company
  • Nevro Corp - Key Facts
  • Nevro Corp - Key Employees
  • Nevro Corp - Key Employee Biographies
  • Nevro Corp - Major Products and Services
  • Nevro Corp - History
  • Nevro Corp - Company Statement
  • Nevro Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Nevro Corp - Business Description
  • Geographical Segment: International
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Nevro Corp - Corporate Strategy
  • Nevro Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Nevro Corp - Strengths
  • Nevro Corp - Weaknesses
  • Nevro Corp - Opportunities
  • Nevro Corp - Threats
  • Nevro Corp - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Nevro Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • Nevro Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
  • Nevro Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • May 05, 2020: Nevro reports first quarter 2020 financial results
  • Apr 01, 2020: Nevro provides first quarter and FY2020 update
  • Jan 20, 2020: Nevro names Donald A. Middlebrook to lead clinical, regulatory and quality
  • Jan 14, 2020: Nevro announces preliminary unaudited fourth quarter and full year 2019 revenue
  • Dec 18, 2019: ­Nevro appoints Karen N. Prange to the company's board of directors
  • Nov 06, 2019: Nevro reports third quarter 2019 financial results
  • Aug 08, 2019: Nevro reports second quarter 2019 financial results
  • Jun 25, 2019: Nevro announces executive appointments
  • May 20, 2019: Nevro appoints D. Keith Grossman Chairman of the Board; Michael DeMane as Lead Director
  • May 09, 2019: Nevro reports first quarter 2019 financial results
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Nevro Corp, Key Facts
  • Nevro Corp, Key Employees
  • Nevro Corp, Key Employee Biographies
  • Nevro Corp, Major Products and Services
  • Nevro Corp, History
  • Nevro Corp, Subsidiaries
  • Nevro Corp, Key Competitors
  • Nevro Corp, Ratios based on current share price
  • Nevro Corp, Annual Ratios
  • Nevro Corp, Annual Ratios (Cont...1)
  • Nevro Corp, Interim Ratios
  • Nevro Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • Nevro Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
  • Nevro Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nevro Corp, Performance Chart (2015 - 2019)
  • Nevro Corp, Ratio Charts
  • Nevro Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
  • Nevro Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Stimwave Technologies Inc
  • Saluda Medical Pty Ltd
  • NeuSpera Medical Inc
  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll